In this review, InduPro Scientific Founders and Leadersip- Rob Oslund, Pamela Holland, Scott Lesley, and Niyi Fadeyi– discuss the progress and impact of cis-bispecific antibodies (cis-bsAbs) in the clinic, their wide-ranging clinical applications, and untangle the intricacies of improving bsAb discovery and development.
